Clinical Trial Update: Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis) [Phase 3]

View source ↗

Summary

Phase 3 trial in adult and adolescent subjects with perennial allergic rhinitis completed; results were posted in May 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED | Results posted: 2012-05-23